Trial intelligence / Profile preview

Latanoprost Gel vs Mometasone Cream with Phototherapy for Pediatric Vitiligo

NCT07016113Phase 2Not yet recruiting

Sponsor
Universitas Padjadjaran
Start
Jul 2025
Primary completion
Oct 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of latanoprost in Vitiligo, sponsored by Universitas Padjadjaran. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

latanoprost
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT07016113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07016113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call